George L. Sing - 22 Feb 2024 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
Director
Signature
/s/**George L. Sing
Issuer symbol
REGN
Transactions as of
22 Feb 2024
Net transactions value
-$1,940,845
Form type
4
Filing time
26 Feb 2024, 16:07:25 UTC
Previous filing
12 Feb 2024
Next filing
28 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Options Exercise $413,330 +1,000 +3.8% $413.33 27,349 22 Feb 2024 Direct
transaction REGN Common Stock Sale $970,000 -1,000 -3.7% $970.00 26,349 22 Feb 2024 Direct
transaction REGN Common Stock Options Exercise $413,330 +1,000 +3.8% $413.33 27,349 22 Feb 2024 Direct
transaction REGN Common Stock Sale $965,000 -1,000 -3.7% $965.00 26,349 22 Feb 2024 Direct
transaction REGN Common Stock Options Exercise $413,330 +1,000 +3.8% $413.33 27,349 22 Feb 2024 Direct
transaction REGN Common Stock Sale $960,000 -1,000 -3.7% $960.00 26,349 22 Feb 2024 Direct
transaction REGN Common Stock Options Exercise $206,665 +500 +1.9% $413.33 26,849 23 Feb 2024 Direct
transaction REGN Common Stock Sale $492,500 -500 -1.9% $985.00 26,349 23 Feb 2024 Direct
holding REGN Common Stock 750 22 Feb 2024 by Spouse
holding REGN Common Stock 400 22 Feb 2024 by Spouse/Cust Son
holding REGN Common Stock 1,000 22 Feb 2024 by Trust for Son

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -3,000 -30% $0.000000 6,838 22 Feb 2024 Common Stock 3,000 $413.33 Direct F1
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -500 -7.3% $0.000000 6,338 23 Feb 2024 Common Stock 500 $413.33 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.